Waaxda Caalamiga ah

Maarso 21, 2025, Junshi Biosciences waxay ku dhawaaqday in Maamulka Badeecadaha Caafimaadka Qaranka ("NMPA") uu ansixiyay codsiga daawada cusub ee dheeraadka ah ("sNDA") ee badeecada shirkadda, toripalimab, iyadoo lagu darayo bevacizumab si loogu daaweeyo safka koowaad ee aan la tirtiri karin ama aan la daaweyn karin...Akhriso wax dheeraad ah»

Maarso 21, 2025, waxay ku dhawaaqday in Codsiga Daawada Cusub ("NDA") ee TAZVERIK® (tazemetostat) la siiyay oggolaansho shuruudaysan oo lagu daaweynayo bukaanada qaangaarka ah ee qaba lymphoma follicular ee soo noqnoqda ama aan firfircoonayn ("R/R") (FL) oo leh isbeddel EZH2 ah kuwaas oo helay ugu yaraan laba jeer ka hor ...Akhriso wax dheeraad ah»

Maarso 10, 2025, Sichuan Kelun-Biotech waxay ku dhawaaqday in antigen-ka 2 (TROP2) ee shirkadda ee loo yaqaan 'trophoblast cell-surface antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, oo hore u ahayd SKB264/MK-2870) loo ansixiyay suuqgeynta Maamulka Badeecadaha Caafimaadka Qaranka (NMPA...Akhriso wax dheeraad ah»

Maarso 18, 2025, Alphamab Oncology waxay ku dhawaaqday in isku-darka daawada antibody-ga ee laba-paratopic-ka ah ee ka hortagga HER2 (ADC) JSKN003 la siiyay Magacaabista Daaweynta Degdegga ah ee Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA). Magacaabista waxaa loogu talagalay daaweynta ...Akhriso wax dheeraad ah»

Maarso 10, 2025, Hansoh Pharma waxay ku dhawaaqday in Codsiga Daawada Cusub ee saddexaad ("NDA") ee daawada cusub ee Kooxda Ameile (阿美乐®) (Aumolertinib Mesilate Tablets) ay ansixisay Maamulka Badeecadaha Caafimaadka ee Qaranka ee Shiinaha ("NMPA") si loogu daaweeyo bukaanada qaba...Akhriso wax dheeraad ah»

Maarso 12, 2025, Zai Lab Limited ayaa ku dhawaaqday in Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) uu aqbalay Codsiga Ruqsadda Bayoolajiga (BLA) ee TIVDAK (tisotumab vedotin-tftv) si loogu daaweeyo bukaanada qaba kansarka ilmo-galeenka ee soo noqnoqda ama faafa oo leh cudurka oo ku dhaca...Akhriso wax dheeraad ah»

Maarso 5, 2025, Ascentage Pharma waxay ku dhawaaqday in dawadeeda, olverembatinib, ay Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) siisay Magacaabista Daaweynta Degdegga ah (BTD), si loogu daro kiimoterabiga xooggan ee ugu horreeya...Akhriso wax dheeraad ah»

Maarso 4, 2025, BeiGene waxay ku dhawaaqday in Maamulka Cuntada iyo Dawooyinka ee Mareykanka (FDA) uu ansixiyay TEVIMBRA (tislelizumab-jsgr), oo ay weheliso kiimoterabiga ka kooban platinum, si loogu daaweeyo dadka waaweyn ee qaba kansarka unugyada squamous ee esophageal ee aan la jari karin ama metastatic metastatic (ESCC) kuwaas oo ...Akhriso wax dheeraad ah»

Febraayo 25, 2025, Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) ayaa ansixiyay finotonlimab oo ay weheliso SCT510 si loogu daaweeyo kansarka beerka ee aan la jari karin ama aan la daaweyn karin oo aan hore loo helin daaweyn nidaamsan. Finotonlimab waa IgG4 oo dib loo habeeyay oo bani'aadamnimo ah...Akhriso wax dheeraad ah»

Febraayo 8, 2025, Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ee Shiinaha ayaa ansixiyay finotonlimab-ka Sinocelltech Group Ltd, oo ah antibody monoclonal ah oo dhimasho 1 (PD-1) ah (mAb) oo barnaamij lagu sameeyay, in lagu isticmaalo iyadoo lala kaashanayo kiimoterabiga ku salaysan platinum-ka oo ah daawaynta koowaad ee soo noqnoqda iyo/ama metas-ka...Akhriso wax dheeraad ah»

Febraayo 21, 2025, Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) ayaa ansixisay Magacaabista Daaweynta Degdegga ah (BTD) ee Satri-cel (CT041) (musharax u taagan badeecada unugyada T-cell ee CAR ee ka dhanka ah Claudin18.2), ee loogu talagalay qalliinka caloosha/hunguriga ee horumarsan...Akhriso wax dheeraad ah»

Febraayo 22, 2025, Codsiga Daawada Cusub (NDA) ee duritaanka ipilimumab (anti-CTLA-4 monoclonal antibody; R&D Code: IBI310) waxaa aqbashay Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) waxaana la siiyay magacaabista Dib-u-eegista Mudnaanta ee com...Akhriso wax dheeraad ah»